FDA Input On Coburn Drug Import Amendment Should Be Sought, Rep. Says
Executive Summary
Congressional legislators should work with FDA on the final language of an amendment proposed by Rep. Coburn (R-Okla.) relaxing importation of drugs, Rep. Kaptur (D-Ohio) suggested during floor debate July 10.
You may also be interested in...
Rx Imports: House Language May Be Preferred By Industry In Conference
Brand name pharmaceutical companies could end up having to support the House drug import provisions in the Agriculture Appropriations bill as a way of avoiding a change to the Food, Drug & Cosmetic Act allowing for the importation of drugs.
Rx Imports: House Language May Be Preferred By Industry In Conference
Brand name pharmaceutical companies could end up having to support the House drug import provisions in the Agriculture Appropriations bill as a way of avoiding a change to the Food, Drug & Cosmetic Act allowing for the importation of drugs.
FDA May Revise Import Notices; Bills Would Jeopardize Safety, Agency Says
FDA is considering changes to its import warning notice procedures, the agency said in a July 25 letter to Commerce Committee Ranking Democrat Dingell (Mich.).
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: